PH31375A - Antimicrobial quinolonyl lactam esters. - Google Patents

Antimicrobial quinolonyl lactam esters.

Info

Publication number
PH31375A
PH31375A PH39403A PH39403A PH31375A PH 31375 A PH31375 A PH 31375A PH 39403 A PH39403 A PH 39403A PH 39403 A PH39403 A PH 39403A PH 31375 A PH31375 A PH 31375A
Authority
PH
Philippines
Prior art keywords
antimicrobial
lactam
quinolonyl lactam
esters
lactam esters
Prior art date
Application number
PH39403A
Other languages
English (en)
Inventor
Ronald E White
Thomas P Demuth
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Publication of PH31375A publication Critical patent/PH31375A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16Nitrogen atoms
    • C07D463/18Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PH39403A 1988-10-24 1989-10-24 Antimicrobial quinolonyl lactam esters. PH31375A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26179888A 1988-10-24 1988-10-24
US41803389A 1989-10-12 1989-10-12

Publications (1)

Publication Number Publication Date
PH31375A true PH31375A (en) 1998-10-29

Family

ID=26948845

Family Applications (1)

Application Number Title Priority Date Filing Date
PH39403A PH31375A (en) 1988-10-24 1989-10-24 Antimicrobial quinolonyl lactam esters.

Country Status (14)

Country Link
EP (1) EP0366641B1 (de)
JP (1) JPH03502933A (de)
KR (1) KR0157297B1 (de)
AT (1) ATE194353T1 (de)
AU (1) AU635226B2 (de)
CA (1) CA2001201C (de)
DE (1) DE68929227T2 (de)
DK (1) DK527489A (de)
ES (1) ES2148135T3 (de)
GR (1) GR3034367T3 (de)
NZ (1) NZ231110A (de)
PH (1) PH31375A (de)
SG (1) SG67307A1 (de)
WO (1) WO1990004594A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147871A (en) * 1986-07-03 1992-09-15 Hoffmann La-Roche, Inc. Anti-bacterial cephalosporin compounds
US5336768A (en) * 1988-05-24 1994-08-09 Hoffmann-La Roche Inc. Antibacterial cephalosporin compounds
CS273349B2 (en) * 1988-03-31 1991-03-12 Hoffmann La Roche Method of cephalosporin's new derivatives production
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
EP0366189A3 (de) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Antimikrobielle Lactam-Quinolone
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
US5162523A (en) * 1989-07-21 1992-11-10 Hoffmann-La Roche Inc. Cephalosporin antibacterial compounds
US5159077A (en) * 1989-07-21 1992-10-27 Hoffmann-La Roche Inc. Penam antibacterial compounds
AU636913B2 (en) * 1989-10-11 1993-05-13 Takeda Chemical Industries Ltd. Tricyclic carbapenem compounds
ZA912279B (en) * 1990-04-09 1992-02-26 Hoffmann La Roche Carbapenem compounds
ATE193890T1 (de) * 1990-04-18 2000-06-15 Procter & Gamble Pharma Antimikrobielle chinolonyl-lactame
HUT67423A (en) * 1991-10-01 1995-04-28 Procter & Gamble Pharma Process for the production of antimicrobal compounds containing quinolone moiety and beta-lactam moiety
DE4234330A1 (de) * 1992-10-12 1994-04-14 Bayer Ag Chinoloncarbonsäuren
KR100242355B1 (ko) * 1994-08-02 2000-03-02 데이비드 엠 모이어 항미생물 화합물의 제조 방법
MX9700872A (es) * 1994-08-02 1997-05-31 Procter & Gamble Procedimiento para producir antimicrobianos de quinolonil-lactama y compuestos intermediarios novedosos.
US9670179B1 (en) * 2013-03-14 2017-06-06 University Of South Florida Antibiotic compositions and methods of use
CN105753887A (zh) * 2016-02-05 2016-07-13 东南大学 一种具有喹诺酮和β-内酰胺结构的化合物及其合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4794109A (en) * 1982-11-16 1988-12-27 Ciba-Geigy Corporation 6-hydroxy-lower alkylpenem compounds, pharmaceutical preparations that contain these compounds, and the use of the latter
GB2164334B (en) * 1984-09-10 1988-08-03 Hoechst Uk Ltd Antibacterial 7-oxo-4-thia-1-azabicyclo 3,2,0 hept-2-ene derivativess
US4861768A (en) * 1986-02-27 1989-08-29 Taiho Pharmaceutical Company, Limited 2 β-substituted thiomethylpenicillin derivatives and their preparation and use
ZA874696B (en) * 1986-07-03 1988-01-04 F. Hoffmann-La Roche & Co. Aktiengesellschaft Acyl derivatives

Also Published As

Publication number Publication date
NZ231110A (en) 1992-06-25
HK1013984A1 (en) 1999-09-17
DK527489D0 (da) 1989-10-24
GR3034367T3 (en) 2000-12-29
DK527489A (da) 1990-04-25
ATE194353T1 (de) 2000-07-15
JPH03502933A (ja) 1991-07-04
CA2001201C (en) 1998-12-22
KR0157297B1 (ko) 1998-11-16
KR900006343A (ko) 1990-05-08
ES2148135T3 (es) 2000-10-16
EP0366641A2 (de) 1990-05-02
EP0366641A3 (de) 1991-12-11
EP0366641B1 (de) 2000-07-05
AU4369489A (en) 1990-05-03
DE68929227T2 (de) 2001-05-31
SG67307A1 (en) 1999-09-21
WO1990004594A1 (en) 1990-05-03
CA2001201A1 (en) 1990-04-24
DE68929227D1 (de) 2000-08-10
AU635226B2 (en) 1993-03-18

Similar Documents

Publication Publication Date Title
PH31375A (en) Antimicrobial quinolonyl lactam esters.
KR100202474B1 (en) Novel tetrapeptide derivative
EP0366193A3 (de) Antimikrobielle Quinolonyllactame
IL90271A0 (en) Antiviral drug
AU1639888A (en) Novel oxetanocins
HUT50345A (en) Process for production of cefem-derivatives and their intermediers
EP0481756A3 (en) Benzamide derivatives
IL102670A0 (en) N-alkylated 1,4-dihydropyridine dicarboxylic acid esters,their preparation and pharmaceutical compositions containing them
MY106269A (en) Novel antimicrobial quinolonyl lactam esters.
TW258733B (de)
MY106321A (en) Novel antimicrobial quinolonyl lactams
EP0589318A3 (de)
YU14488A (en) 6-beta(substituted)-(s)-hydroxymethyl-penicillanic acids and their derivatives
AU7613594A (en) Use of n-alkylated 1,4-dihydropyridine dicarboxylic acid esters as medicaments
EP0381114A3 (de) Exo-3'-4'-O-benzyliden-3"-demethylchartreusin und seine Salze
NZ231087A (en) Piperidino-ethoxy benzoyl benzoate derivatives and pharmaceutical compositions
TW265342B (de)
AU1121892A (en) Isoquinoline derivatives
ZA928165B (en) Pharmaceuticals "pyridine-3-carboxylic acid esters or amides useful as 5-ht3antagonists".
KR0162983B1 (en) Novel antimicrobial quinolonyl lactam esters